英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：


请选择你想看的字典辞典：
单词字典翻译
Pawed查看　Pawed　在百度字典中的解释百度英翻中〔查看〕
Pawed查看　Pawed　在Google字典中的解释Google英翻中〔查看〕
Pawed查看　Pawed　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • Study Details | NCT02655692 | CAP-Ketamine for Antidepressant Resistant . . .
    The purpose of this study is to test the safety and efficacy of repeated doses of ketamine as compared to placebo, in reducing symptoms of Posttraumatic Stress Disorder (PTSD) in an active duty military and Veteran population
  • Trial | NCT02655692
    Trial | NCT02655692 Report issue participants: Study Overview Official Title CAP-Ketamine for Antidepressant Resistant PTSD Snapshot Phase Phase 2 Lead Sponsor Department of Veteran Affairs Study Type Interventional Status CompletedResults Posted Indication Condition PTSD Posttraumatic Stress Disorder Intervention Treatment
  • CAP-Ketamine for Antidepressant Resistant PTSD | Huxley
    Sponsored by VA Office of Research and Development NCT ID NCT02655692 Target Enrollment 163 participants Start Date 2016-04-18 Est Completion 2020-07-01
  • CAP-Ketamine for Antidepressant Resistant PTSD
    VA Office of Research and Development Status and phase Completed Phase 2 Conditions Posttraumatic Stress Disorder PTSD Treatments Drug: Placebo Saline Drug: Ketamine Study type Interventional Funder types Other Other U S Federal agency Identifier s NCT02655692 SPLE-003-14W Take notes View 3 locations
  • Microsoft Word - 3. 31. 2021 CAP JK0069 Protocol clean. docx
    PTSD is the psychiatric disorder that can be most directly attributed to participation in combat Thus the Department of Veterans Affairs and Department of Defense have a unique responsibility to identify and implement effective treatments for military personnel and Veterans suffering from PTSD
  • CAP-Ketamine for Antidepressant Resistant PTSD | MedPath
    Phase 2 Completed Conditions PTSD Posttraumatic Stress Disorder Interventions Drug: Placebo Saline Drug: Ketamine Feedback Registration Number NCT02655692 Lead Sponsor VA Office of Research and Development Brief Summary
  • UT Health San Antonio
    Study Contact Detailed Description This study (NCT02655692) was last processed and updated on 5 6 2022 by ClinicalTrials gov
  • CAP-Ketamine for Antidepressant Resistant PTSD
    In this 2-site clinical trial, intended to evaluate the safety and efficacy of repeated doses of ketamine for treatment resistant PTSD, Veterans and active duty military personnel who meet criteria for PTSD and the additional inclusion and exclusion criteria will be randomized to one of three treatment arms (placebo, low dose ketamine, high dose ketamine) Participants receive the study drug
  • NCT02655692: A trial that was reported late by VA . . . - TrialsTracker
    This trial has reported, although it was 116 days late in doing so ACT or pACT? Built by the Bennett Institute for Applied Data Science, University of Oxford Data last updated 20 May 2026 Next planned update 21 May 2026 Problems? Feedback? Get in touch
  • Dose-related effects of ketamine for antidepressant-resistant symptoms . . .
    Further studies are needed to determine the role of ketamine in PTSD treatment ClinicalTrials gov identi er: NCT02655692 Posttraumatic stress disorder (PTSD) is a debilitating illness with limited pharmacotherapy options [1–3]





中文字典-英文字典  2005-2009